Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Prof. Dr. Tianhui Yuan | Medicine and Health Sciences | Best Researcher Award

Associate Director | The First Affiliated Hospital of Guangzhou University of Medicine | China

Prof. Dr. Tianhui Yuan is a distinguished physician-scientist whose educational journey culminated in the M.D. and a Ph.D. in integrated medicine and cardiovascular science (with doctoral training at a leading university), and she currently serves as Chief Physician, Doctoral Supervisor, and Associate Director of her department while also holding a Visiting Scholar appointment in the United States. Over her career, she has held progressive roles in clinical practice, laboratory research, and academic leadership in integrative Chinese and Western medicine. Her professional experience spans directing clinical care units in cardiovascular medicine, mentoring doctoral and postdoctoral researchers, coordinating international research collaborations, and representing her institution in health policy and traditional medicine networks. Her research interests lie at the interface between traditional Chinese medicine and modern cardiovascular disease therapy, particularly focusing on mechanisms and therapeutic strategies for heart failure, cardiomyopathy, coronary artery disease, hypertension, arrhythmia, hyperlipidemia, and insomnia. She is skilled in experimental cardiovascular physiology, molecular biology, signaling pathway analysis, preclinical animal models, translational interventions, and clinical guideline development. She has made significant scholarly contributions: she has authored 15 documents, received 154 Citations, and holds an h-index of 7, reflecting a growing impact. Among her honors and awards, she has been selected for the Guangdong Provincial Health Commission’s “Guangdong Special Support Program” and the “Youth Talent Support Program,” and she holds recognition as a young academic leader at her university; she also serves on multiple national and international professional committees and has contributed to guideline development, patent filing (2 invention patents), software intellectual property (1 software copyright), and the authorship of 9 books. Through mentorship she has guided student teams to high distinction in innovation competitions and has been invited as a keynote speaker at major conferences like the ESC Heart Failure Congress and the International Heart Congress. Given her solid educational foundation, extensive clinical and research experience, integrative medicine focus, leadership roles, and peer-recognized contributions, Prof. Dr. Tianhui Yuan is exceptionally well positioned to advance her field further, strengthen international collaborations, expand high-impact publication outputs, and mentor the next generation of integrative cardiovascular researchers.

Profile: Scopus

Featured Publications

  1. Ma, X., … Yuan, T. (2023). Regulation of phospholipid peroxidation signaling by a traditional Chinese medicine formula to prevent myocardial ischemia. Journal Name.

  2. Dong, X., Han, X., Zhang, X., … Yuan, T. (2022). A simplified herbal formula improves cardiac function and reduces inflammation in mice through the TLR-mediated NF-κB signaling pathway. Journal Name.

  3. Yang, Z., Xian, S., Yuan, T. (2020). Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury. Journal Name.

  4. Yuan, T., Chen, Y., Zhou, X., … (2019). Effectiveness and safety of Danshen injection on heart failure: protocol for a systematic review and meta-analysis. Journal Name.

  5. Wang, L., Gao, M., Chen, J., … (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. Journal Name.

 

Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Prof. Dr. Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Professor, University of Zielona Gora, Poland

Prof. Dr. Radoslaw Kazmierski is a distinguished researcher whose expertise lies in neurology, stroke medicine, and cerebrovascular disorders. He has contributed significantly to advancing knowledge in stroke prevention, diagnosis, and treatment through his clinical and translational research. He holds a Ph.D. in medicine with specialization in neurological sciences, which has shaped his academic and research pursuits. Prof. Dr. Radoslaw Kazmierski has actively collaborated on international research projects focusing on stroke risk stratification and cognitive impairment, bringing a global perspective to his work. He has authored 49 documents, accumulating 781 citations with an h-index of 14, demonstrating the academic impact and relevance of his research within the medical community. His publication portfolio includes papers in reputed journals indexed in Scopus and other high-impact platforms, making a substantial contribution to evidence-based medicine. Prof. Dr. Radoslaw Kazmierski has also engaged in leadership roles within academic and clinical research settings, mentoring young researchers and guiding clinical trials. He has been associated with professional memberships in neurology associations and continues to contribute to advancing stroke awareness and patient care standards. His work bridges academia, clinical application, and community health initiatives, making him a valuable contributor to global neurological research.

ProfileScopus | ORCID

Featured Publications

  1. Short-term outcome after ischemic stroke and 24-h blood pressure variability: association and predictors — 2021; cited by multiple studies as a key predictor model.

  2. Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients — 2011; widely cited in studies of redox biomarkers and stroke prognosis.

  3. Zaburzenia mowy i języka u pacjentów po przebytym udarze mózgu. Studium epidemiologiczne — 2022; epidemiological study of speech and language disorders post-stroke; though newer, it contributes to functional outcomes research.